Stratview Research has recently published a report on the Synthetic Biology Market. This strategically evaluated report provides a detailed overview that presents today's market scenario and future possibilities, as well as market intelligence and information, for a 5-year period from 2022 to 2028.

The Synthetic Biology Market is Segmented by Tool Type (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids), by Technology Type (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement & Modeling, Microfluidics, and Nanotechnology), by End-Use Industry Type (Medical, Industrial, Food & Agriculture, and Environmental), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

Synthetic Biology Market Analysis:

Stratview Research’s report discusses the segment-wise current market condition. Also, it offers an estimation of future growth opportunities. As per the estimation, the Synthetic Biology Market is estimated to grow from USD 12.1 billion in 2022 to USD 43.9 billion by 2028 at a healthy CAGR of 23.9% during the forecast 2022-2028..

Some of the companies drive the market growth:

• Agilent Technologies, Inc.,
• Amyris, Inc.,
• Codexis, Inc.,
• Creative Enzymes,
• Cyrus Biotechnology Inc.,
• Eurofins Scientific,
• GenScript Biotech Corporation,
• Ginkgo Bioworks,
• Integrated DNA Technologies, Inc.,
• New England Biolabs,
• Novozymes A/S,
• Precigen, Inc.,
• Synthego Corporation,
• Synthetic Genomics, Inc.,
• The Merck Group,
• Thermo Fisher Scientific Inc., 
• Twist Bioscience.

To download a free sample of the report, Click Here: https://www.stratviewresearch.com/Request-Sample/846/synthetic-biology-market.html#form

Segments Analysis

By Tool Type

The market is segmented as oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides & synthetic DNA segment held the largest share of the market in 2019, and is expected to remain dominant during the forecast period. The growing demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of research applications is propelling the segment’s market.

Region Analysis

Asia-Pacific is estimated to be the largest market during the forecast period, with China, Japan, India, and Australia being the major countries with lucrative growth opportunities. This growth can be attributed to the presence of major synthetic biology companies in the region. Availability of funds for research from government organizations, advancing efforts to increase the output of the healthcare industry, rising demand for high-quality research tools for data reproducibility, and increasing focus on development of personalized therapeutics are some prime factors driving the region’s synthetic biology market.

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].